29.05.2018 Views

Asia-Pacific In-vitro Fertilization Services Market to Reach $7.1 Bn, by 2022

The Asia-Pacific IVF cycle market is characterized by improvement in standards of living, increasing number of couples delaying parenthood due to professional commitments, and trends towards financial stability. Get sample copy of this report: https://www.alliedmarketresearch.com/request-sample/853.

The Asia-Pacific IVF cycle market is characterized by improvement in standards of living, increasing number of couples delaying parenthood due to professional commitments, and trends towards financial stability.
Get sample copy of this report: https://www.alliedmarketresearch.com/request-sample/853.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Asia</strong>-<strong>Pacific</strong><br />

<strong>In</strong>-<strong>vitro</strong><br />

<strong>Fertilization</strong><br />

(IVF)<br />

<strong>Services</strong><br />

<strong>Market</strong><br />

Opportunities<br />

and<br />

Forecasts<br />

2014 – <strong>2022</strong>


<strong>Asia</strong>-<strong>Pacific</strong> <strong>In</strong>-Vitro <strong>Fertilization</strong> (IVF) <strong>Services</strong><br />

<strong>Market</strong>– <strong>In</strong>troduction<br />

The <strong>Asia</strong>-<strong>Pacific</strong> <strong>In</strong>-<strong>vitro</strong> <strong>Fertilization</strong> <strong>Market</strong> is expected <strong>to</strong> reach $7 billion <strong>by</strong> <strong>2022</strong>,<br />

growing at a CAGR of 13.3% from 2016 <strong>to</strong> <strong>2022</strong>. The fresh cycle (non-donor) segment<br />

accounted for approximately three-fourths share in 2015 and is expected <strong>to</strong> maintain<br />

its dominance during the forecast period.<br />

The rapidly growing geriatric population has been a major concern for the<br />

government in most of the countries in the <strong>Asia</strong>-<strong>Pacific</strong> region. Several countries, such<br />

as Vietnam, Cambodia, and Philippines, have fertility rates of 2 births per woman,<br />

which is below the average rate of 2.1 births per woman. These countries are keen on<br />

boosting their fertility rates <strong>to</strong> maintain balance between new born and geriatric<br />

populations. <strong>In</strong>donesia in particular had a fertility rate of 2.1 and geriatric population<br />

of about 5% of the <strong>to</strong>tal population in 2015. According <strong>to</strong> Ageing<strong>Asia</strong>.org, this number<br />

is anticipated <strong>to</strong> reach 74 million <strong>by</strong> 2050. Korea, which had a fertility rate of 1.25 in<br />

2014, has announced financial support for infertility treatment. Similarly, Singapore,<br />

with fertility rate of 0.80 in 2014, has increased the subsidy for treatment <strong>to</strong> 75% of<br />

the treatment cost. These fac<strong>to</strong>rs have been instrumental in driving the growth of the<br />

<strong>Asia</strong>-<strong>Pacific</strong> IVF cycle market.


<strong>In</strong>troduction<br />

Scope of<br />

the Report<br />

Key Benefits<br />

Key Audiences


KeyBenefits<br />

<strong>In</strong>troduction <strong>to</strong>Smart Syringes <strong>Market</strong><br />

✓ This report provides an in-depth analysis of the <strong>Asia</strong>-<strong>Pacific</strong> IVF<br />

market across twelve major countries along with cross sectional<br />

Synthetic biology is a novel analysis areaof ofthe research <strong>to</strong>tal number that is theof amalgamation IVF cycles performed of multiple disciplines and the <strong>to</strong>tal such<br />

as molecular biology, biotechnology, biophysics and genetic engineering among others. There are<br />

revenue generated during the forecast period.<br />

chiefly two approaches used in synthetic biology namely, <strong>to</strong>p down approach and bot<strong>to</strong>m up<br />

approach. Top-down approach involves the re-design and fabrication of existing biological systems<br />

for producing synthetic ✓ The products. report Bot<strong>to</strong>m-up includes the approach strategies involves adopted designing <strong>by</strong> various and construction IVF clinics of de<br />

novo biological systems or devices that do not exist in nature.<br />

and hospitals across major countries <strong>to</strong> capitalize on the latent<br />

opportunities in the <strong>Asia</strong>-<strong>Pacific</strong> IVF market.<br />

World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23%<br />

during the forecast period. Assistance from government and private organizations, rising number of<br />

synthetic biology research ✓ This entities report and comprehensively declining cost of analyzes DNA sequencing the market & synthesizing scenario across are the<br />

major fac<strong>to</strong>rs driving the different market countries growth. Onin the the contrary, <strong>Asia</strong>-<strong>Pacific</strong> bio-safety region. & bio-security issues, would<br />

hinder the market growth. The issues related <strong>to</strong> the misuse of synthetic biology or possibilities of<br />

accidental release of pathogens in<strong>to</strong> free atmosphere would remain as a key challenge worldwide.<br />

However, rising demand ✓ The forprojections bio-fuels, growing in this awareness report are inmade emerging <strong>by</strong> analyzing economiesthe andcurrent<br />

rising R&D<br />

investments for synthetic drugs and vaccines would offer lucrative opportunities in the market<br />

market trends and highlighting the market potential, in terms of<br />

value and volume, from 2015 <strong>to</strong> <strong>2022</strong>.<br />

✓ Extensive analysis of the market is conducted <strong>by</strong> following the key<br />

product positioning and moni<strong>to</strong>ring the <strong>to</strong>p contenders.


Table ofContents:<br />

1. <strong>In</strong>troduction<br />

2. Executive Summary<br />

3. <strong>Asia</strong>-pacific IVF <strong>Market</strong> Analysis<br />

4. <strong>In</strong>dia IVF <strong>Market</strong><br />

5. China IVF <strong>Market</strong><br />

6. Japan IVF <strong>Market</strong><br />

7. Australia IVF <strong>Market</strong><br />

8. New Zealand IVF <strong>Market</strong><br />

9. Thailand IVF <strong>Market</strong><br />

10. Singapore IVF <strong>Market</strong><br />

11. Malaysian IVF <strong>Market</strong><br />

12. <strong>In</strong>donesian IVF <strong>Market</strong><br />

13. Philippines IVF <strong>Market</strong><br />

14. Rest Of <strong>Asia</strong>-pacific IVF <strong>Market</strong><br />

Enquiry about report at: https://www.alliedmarketresearch.com/purchase-enquiry/853


<strong>Asia</strong>-<strong>Pacific</strong> <strong>In</strong>-Vitro <strong>Fertilization</strong> (IVF) <strong>Services</strong><br />

<strong>Market</strong>– Segments<br />

Key <strong>Market</strong> Segments<br />

End Users<br />

Cycle Type Country<br />

Level Analysis<br />

Cycle Type


<strong>Asia</strong>-<strong>Pacific</strong> <strong>In</strong>-Vitro <strong>Fertilization</strong> (IVF) <strong>Services</strong><br />

<strong>In</strong>troduction <strong>to</strong>Smart Syringes <strong>Market</strong><br />

<strong>Market</strong>– Segments<br />

End Users<br />

Fertility Clinics Hospitals Surgical Centers<br />

Clinical Research<br />

<strong>In</strong>stitutes


<strong>Asia</strong>-<strong>Pacific</strong> <strong>In</strong>-Vitro <strong>Fertilization</strong> (IVF) <strong>Services</strong><br />

<strong>In</strong>troduction <strong>to</strong>Smart Syringes <strong>Market</strong><br />

<strong>Market</strong>– Segments<br />

Cycle Type<br />

Fresh Cycle<br />

(Non-Donor)<br />

Thawed IVF<br />

Cycle (Non-<br />

Donor)<br />

Donor Egg IVF<br />

Cycles


<strong>Asia</strong>-<strong>Pacific</strong> <strong>In</strong>-Vitro <strong>Fertilization</strong> (IVF) <strong>Services</strong><br />

<strong>Market</strong>– Segments<br />

Cycle Type Country<br />

Level Analysis<br />

<strong>In</strong>dia China Japan Australia<br />

New<br />

Zealand<br />

Rest of<br />

<strong>Asia</strong>-<br />

<strong>Pacific</strong>


ThankYou!<br />

For More Details<br />

Visit usat<br />

https://www.alliedmarketresearch.com/asia-<strong>Pacific</strong>-in-<strong>vitro</strong>-fertilization-services-market<br />

Follow Us On

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!